Verrica Pharmaceuticals (VRCA) announced the appointment of Noah Rosenberg, M.D., as Chief Medical Officer, CMO.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRCA:
- Verrica Pharmaceuticals’ Earnings Call: Growth Amid Challenges
- Strategic Growth and Market Positioning Drive Buy Rating for Verrica Pharmaceuticals
- Verrica Pharmaceuticals Reports Positive Q4 2024 Results
- Verrica Pharmaceuticals files $150M mixed securities shelf
- Verrica Pharmaceuticals reports Q4 EPS (24c), consensus (24c)